Healthcare

Unveiling the True Power of the Mediterranean Diet
Global Awareness, Healthcare, Lifestyle Matters, MedHeads

Unveiling the True Power of the Mediterranean Diet

In this episode of Lifestyle Matters.

Can the Mediterranean diet truly help reduce our risk of cardiometabolic, neurodegenerative and cancer related diseases? Does it truly live up to all its glory?’

This week, we focus on what the Mediterranean diet is and the evidence behind some of its benefits.

The ‘true’ form of the Mediterranean diet (MedDiet) is very different from what we know of it today. The classical form of a MedDiet is a whole- foods plant based diet rich in MUFAs and PUFAs, legumes, beans and wholegrains with moderate consumption of red wine with little saturated fat.
(The Australian Guidelines recommend no more than 4 standard drinks / day, capped at 10 standard drinks / week)

The food pyramid below gives us a general overview on the diet:

This diet was popularised in the 60s by Ancel Keys who conducted the Seven Countries Study in which he studied lifestyle factors that affect our risk of developing heart disease.

He demonstrated that hypertension, hypercholesterolemia, and diabetes are undoubtedly risk factors for heart disease. In the same study he also discovered that a diet high in fibre, MUFAs and PUFAs along with low sugar intake i.e < 25gram / day can reduce risk of heart disease and all-cause mortality. This is exactly what the MedDiet is all about.

Other studies, including the Lyons Diet Heart Study, looked at the protective effect of the MedDiet which demonstrated protective heart effects of the diet such as a 73% relative risk reduction for fatal and non-fatal heart attacks , 70% relative risk reduction for overall cause mortality , and significant risk reductions in developing clots in the lungs and legs.

The Predimed Study was another study showing a possible link between high consumption Extra Virgin Olive Oil (EVOO) and risk of breast cancer reduction. Both olive oil polyphenols and Oleuropin have been implicated in this.

Other potential benefits that have been investigated and demonstrated through various studies include:

  • A 50% lower risk of all-cause cancer mortality in certain cancers including prostate, colorectal, head and neck cancers, gastric and pancreatic cancer

  • Reduction in neurocognitive disorders such as dementia, Alzheimers Disease

  • Improve diabetes control – Hba1c reduced from 0.1-0.6% almost comparable to some pharmacological interventions

  • Reduction in the risk of progression to Metabolic Syndrome

  • Weight loss

Our awareness of the benefits we can gain from the MedDiet are increasing. This coupled with the fact that it is certainly not a difficult diet to follow, makes this diet quite favourable.

Mitigating Opioid Risks
Cracking Addiction, Global Awareness, Healthcare

Mitigating Opioid Risks

On Cracking Addiction this week

Legacy patients on high dose opioids or on combination hypno-sedatives including the combination of opioids and benzodiazepines are at an elevated risk of death. The OPQRST mnemonic can be used to conceptualise the strategies that help to mitigate legacy patients’ risk of death and to trend them towards a position of safer prescribing.

  • O= opioid antagonist therapy: take home naloxone

  • P = pharmacotherapy

  • Q = quantity: reduced

  • R = referral to allied health and or psychology

  • R = rotation of opioids

  • S = staged supply

  • T = tapering

Opioid antagonist therapy.
Opioid antagonist therapy in the form of naloxone is available as “Narcan” vials, “Prenoxad” prefilled syringes and as “Nyxoid” nasal spray.

The Pennington institute’s community overdose prevention education program (COPE) provides useful resources and advice regarding the use of naloxone in the management of accidental opioid overdose. It should at this point be stated that naloxone therapy should not be reserved for patients with opioid substance use disorders, but rather should be a widely available therapy for all patients who are at risk of opioid overdose.

Regarding this point, Jauncey and Nielson stated in their 2017 paper that “Regardless of whether opioid use is licit or illicit, anyone at risk of opioid overdose should be considered for naloxone.” It is the author’s opinion therefore, that any patient who is prescribed a total opioid load of more than 50 mg oral morphine equivalent per day should be prescribed naloxone and that they and their carers should be provided with training on its use.

Pharmacotherapy
Suboxone pharmacotherapy can be considered as one option for the treatment of those patients on high dose prescription opioids who meet the diagnostic criteria for an opioid use disorder as defined DSM 5. The distinction needs to be made between physiological dependence and opioid use disorder. Any patient on long term prescribed opioids has the potential to become physiologically dependent on their opioid medication and can therefore present to their clinician requesting higher doses of opioids to treat an apparently worsening pain.

This group of patients can be dealt with by various interventions including a reassessment of underlying medical conditions, alternative pain management interventions (pharmacological or otherwise) opioid rotation or opioid tapering (if deemed appropriate). They must also be distinguished from those patients who present with aberrant behaviours. Such behaviours have been extensively described and include the following.

• Medically unsanctioned use of prescription medication including use of higher doses, unsanctioned indications (non-pain indications e.g. a “bad day”) and unsanctioned routes of ingestion (e.g. snorting or injecting crushed tablets)

• Prescription forgery

• Selling medication

• Doctor shopping

Patents who demonstrate aberrant behaviours with regard to their prescription opioids should be considered for long term pharmacotherapy either with methadone or buprenorphine (with or without naloxone). Each state in Australia has its own rules and regulations regarding the accreditation of clinicians to provide pharmacotherapy and it behoves clinicians to consider their own local requirements before prescribing pharmacotherapy.

Quantity: reduced
It is not mandatory to prescribe quantities as per the original pack size. Smaller quantities of medication should be prescribed per prescription by clinicians who are concerned about the supply of hypno-sedative drugs to their patients.

Referral
Referrals to allied health practitioners and or psychologists should be encouraged as part of a multimodal system of chronic pain management in which the provision of psychological and physical therapies supersede the emphasis on prescribing.

Rotation of opioids
Opioid rotation provides a rapid and effective means of reducing the total daily oral morphine equivalent (OME) daily dose. For patients on more than 100 mg OME, opioid rotation can be used to rapidly reduce the OME to less than 100 mg. It relies on the fact that patients do not usually demonstrate cross tolerance between opioids so converting a patient from one opioid to another necessitates a reduction in dose of the second opioid to approximately fifty percent of the equivalent dose of the first opioid. For instance, if a patient has been prescribed 60 mg b.d. of “Targin” this equates to approximately 200 mg OME. If the patient were to be transferred to 200 mg daily of a long acting morphine, e.g. “MS Contin” or “Kapanol” the patient would likely suffer an overdose because of the lack of cross tolerance between opioids. Therefore, as per the usual practice of only prescribing 50% of the calculated OME for the second opioid, the patient should be started on only 100 mg daily of long acting morphine. It can be seen in this example that converting from oxycodone to morphine has reduced the overall OME from 200 mg to 100 mg. A reduction in OME is an important step in trending the legacy patient to a position of reduced risk of death.

Staged supply
Staged supply denotes the practice of requiring that a patient attend a pharmacy or other dosing point on a regular basis to receive a daily dose of the medication in question. Clinicians can arrange staged supply of any drug, not just Suboxone or methadone. Therefore, staged supply of opioids would be entirely reasonable as part of a plan to manage high dose or high-risk opioid prescribing.

Tapering of opioids
Patients can be weaned off high doses of opioids by gradually reducing their dose over weeks to months. This process, called tapering, is usually done in conjunction with opioid rotation.

The process of tapering involves the following steps.

• The daily dose of short acting opioids is incorporated into a long acting dose of equivalent opioid.
• If multiple opioid combinations are used, then all opioids are converted into an oral morphine equivalent and an opioid rotation is performed as described above.
• One long acting opioid is commenced
• The taper starts at a rate of approximately ten percent per week of the original starting dose
• The use of short acting opioids or prn doses is strictly limited.

The recommended taper rate is a reduction of ten per cent of the original dose of opioid per week or fortnight such that over a period of ten to twenty weeks patients can be completely weaned off their opioids if appropriate or otherwise weaned down to a dose of less than 100 mg OME.

The Portfolio Diet
Global Awareness, Healthcare, Lifestyle Matters, MedHeads

The Portfolio Diet

In this episode of Lifestyle Matters.

This week, Dr Ferghal and I explore the ‘Portfolio Diet’; known for its effectiveness in lowering LDL i.e. ‘bad cholesterol’. This diet is said to be as effective as Lovastatin, which is a cholesterol lowering medication!

Before exploring this further let us gain a basic understanding of what Cholesterol is. Cholesterol is an essential waxy substance in our body that is needed for a variety of important functions including making hormones, building cells, and protecting our brains.

However, it often gets bad reputation, and this is largely due to the LDL (low density lipoprotein) which is the molecule that sticks to damaged parts of our blood vessels. This causes a variety of other cells to latch on to it which eventually forms plaques which can break off at any point and potentially obstruct blood flow to our heart. This obstruction leads to heart attacks.

HDL (high density lipoprotein) on the other hand is a molecule that scavenges excess cholesterol through our body and shuttles it to the liver to get excreted. Hence it is often referred to as the ‘good cholesterol’.

The Portfolio study demonstrated a 30.9% LDL reduction in the cohort that received Lovastatin compared to 28.6% who were on the Portfolio diet. This difference is not clinically significant.

So what exactly os the Portfolio Diet?

  • High plant protein – soy – 50gm/ day

  • High nuts & seeds – 50gm/ day

  • High viscous fibres 10-25gm/ day

  • High plant sterols – 2gm/ day

 It is a diet very rich in fibre and would achieve the current recommendation of 40gm of fibre / day in women and 45gram/day in men which most of us do not usually consume.

How does the Portfolio Diet improve LDL levels?

  • High fibre: Especially soluble fibre. e.g. fruits, vegetables and oats do not get absorbed in the intestines. Instead, they bind to cholesterol molecules thus reducing its absorption

  • High plant sterols : These compete with cholesterol absorption in the gut thereby cholesterol absorption is reduced

But what are plant sterols?

These are naturally occurring cholesterol substances at low levels in plants and fruits. Unfortunately, it is not easy to get enough through our diet hence margarine spreads that are high in plant sterols are recommended.
There has been little evidence supporting this hence the Heart Foundation Guidelines have also recommended consumption of 2-3gm plant sterol / day.

Other potential benefits of this diet include reducing insulin resistance and blood pressure. A study demonstrated a 2 % reduction in blood pressure at 24 weeks compared to the DASH diet (Dietary Approaches to Stop Hypertension) which is quite astounding since this diet’s primary aim was not to reduce blood pressure.

This is undoubtedly not an easy diet to follow but if one can adhere to it strictly, there are certainly many benefits to gain.

Addiction and OUD
Cracking Addiction, Global Awareness, Healthcare

Dependence, Addiction and OUD

On Cracking Addiction this week

The natural history of opioid use is characterised by the development of dependence relatively rapid after 6-8 weeks of regular use or many years of intermittent use and once dependent users may struggle to control their use for substantial proportions of their lives.

 The terms dependence and addiction are often used interchangeably but theses terms actually refer to two different phenomena. Dependence refers to a physiological response and is characterised by tolerance to a substance and withdrawal symptoms when one cannot access this substance. It is characterised by a neuroadaptation to this substance.

 Addiction refers compulsive and uncontrollable use of a substance even in negative circumstances and even when harms are occurring due to this substance usage. Thus one can be dependent on a substance and not addicted and one can use opioids prescribed or illicitly and not have an opioid use disorder.

 The criteria for opioid use disorder is listed below and:

  • meeting 2-3 criteria characterises mild opioid use disorder

  • meeting 4-5 criteria characterises moderate opioid use disorder

  • meeting 6-11 criteria characterises severe opioid use disorder

Opioid use disorder (DSM-5)

2-3 criteria mild, 4-5 moderate, 6-11 severe opioid use disorder

  • 1. impaired control over use

  • 2. Great deal of time spent obtaining, using or recovering from effects of opioids

  • 3. Craving or compulsion to use

  • 4. Unsuccessful attempts to cut down on use

  • 5. Preoccupation with opioid use to the detriment of all other responsibilities

  • 6. Continued opioid use despite negative repercussions

  • 7. Social, occupational or recreational activities abandoned due to opioid use

  • 8. Recurrent opioid use in physically hazardous situations

  • 9. Tolerance

  • 10. Withdrawal or use of opioids to prevent withdrawal

  • 11. Persistent use despite clear evidence of physical or psychological adverse consequences

The ICD 11 criteria for substance dependence recognises that this is a disorder of regulation and requires that two out of three of the following themes need to be present for a diagnosis of substance dependence to be made and that is:

  • impaired control

  • increasing priority of substance use over all other priorities

  • presence of some physiological features whether that be tolerance, withdrawal or neuroadaptation.

Thus one can see that dependence and addiction are two quite different phenomena and how important it is to be clear in our definition and language when discussion both addiction and dependence.

Opioid Replacement Therapy
Global Awareness, Healthcare, MedHeads

Understanding Opioid Replacement Therapy

On Cracking Addiction this week

In 2012 heroin was responsible for 30% of all drug deaths in Australia. People who are addicted to heroin are more than four times to die than the general population with the three commonest causes of death being polysubstance overdose, trauma and suicide. We know that people who use heroin or illicit opioids are 5 times more likely to die prematurely than the general population.

Opioid replacement therapy (ORT) is the replacement of a drug of dependence such as heroin with a legally prescribed opioid substitute with a stable and long half life such as Methadone or Suboxone which helps reduce cravings and the cycles of withdrawal. The use of Methadone and Suboxone in ORT is a form of harm reduction and it realises that for a number of reasons there are some people who are unable to remain abstinent of drugs and replacement therapy is a safer alternative.

Methadone maintenance therapy reduces heroin use, injecting behaviours and mortality and we know that by commencing ORT patients are:

  • more likely engage in healthcare

  • results in improved physical and psychological health

  • decreases criminal behaviour

  • increases social and community engagement

  • decreases harms associated with injecting drug behaviour

ORT has been present and used for a number of decades and has been extensively researched and has a good evidence base for it’s effectiveness. It is something that is within the realm of all general practitioners and doctors and something that should be thought about and utilised more frequently than it currently is.

Low carb high fat diet
Global Awareness, Healthcare, Lifestyle Matters, MedHeads

Low carb high fat diet

In this episode of Lifestyle Matters.

The highs and the lows of the “Low Carb High Fat” diet.

Many people tend to subscribe to the famous “Low Carb High Fat” diet and others swear by it but a pertinent question to ask is whether these individuals do it well or if they are successful? Can the diet really improve diabetes control?

This week on Lifestyle Matters, Dr Ferghal and I take a deeper dive into the “Low Carb High Fat” diet”.

Before insulin was discovered in the 1920s, a low carbohydrate diet was commonly prescribed to patients with diabetes. The logic was that the lower the carbohydrates consumed, the lower the glucose levels in our bodies. The prescription of this diet for diabetes control persisted despite the discovery of insulin! They were not wrong; there have been many studies demonstrating the efficacy of this diet in weight loss and reduction in insulin resistance. Insulin resistance is one of the underlying factors in the development of diabetes.

When we eat carbohydrates, these get broken down into sugar molecules which then triggers off insulin release for it to be taken up by our cells. If we have diabetes, insulin does not work very effectively, thus our glucose (sugar) levels rise. So, we can see why a low carbohydrate diet was prescribed for diabetes control.

However, long term studies have shown that this diet is not as sustainable as we may think it is. Further, their potential adverse effects from this diet which we will explore below.

Firstly, let us study the amount of energy we should obtain from various macronutrients.

As seen in the chart above, 45-65% of energy intake = 225-325gm of carbohydrate / day.

There are a few different types of low carb diets:
• Very low: 20-50gm of carbs/ day (most effective, almost ketogenic)
• Low: < 130gm / day
• Moderate: < 230gm/ day

The reality is this; it is not easy to sustain a very low carbohydrate diet beyond 6-12 months. Many people fall back onto a low and moderate carbohydrate intake which does not produce results as effective as a very low carbohydrate diet. Further, people tend to increase their protein intake while on this diet which commonly is achieved through a higher meat intake i.e. saturated fat.

We know red meat have other detrimental effects to our health as it is classified as a Group 2A Carcinogenic Food by the World Health Organisation.

It is imperative to keep the saturated fat to < 10 % if one were to follow this diet. This is also extremely important for those who suffer with hypertriglyceridemia (where their triglycerides > 500 mg / dL ) as the ability to remove triglyceride enriched lipoproteins are saturated and can lead to pancreatitis. This shows the indirect effects of going on a low-carb diet.

There are other adverse outcomes from consuming a low carbohydrate diet over long term such as:

• Osteoporosis: Various mechanisms have been identified in rat models (watch this space!)
• Deficiency in vitamins and minerals: Dietary fibre, Magnesium, Phytochemicals that are usually found in complex carbohydrates.

In summary, the key message from this is that if a low carbohydrate high fat diet suits one’s lifestyle it is a reasonable choice as it certainly does demonstrate several benefits. However, due to issues with its sustainability and potential negative implications on our health, it may make it less than an ideal diet to stick to beyond a year.

Methadone Treatment for Opioid Addiction
Cracking Addiction, Global Awareness, Healthcare

Methadone Treatment for Opioid Addiction

On Cracking Addiction this week

Methadone was developed in Germany in 1941 as a synthetic opioid agonist. It was in 1961 that Dole and Nyswander suggested it could be used as opioid agonist therapy in the treatment of heroin addiction.

Methadone is an extensively investigated treatment in opioid agonist therapy. A 30 year observational study by Grella and his colleagues in 2011 found that 25% of patients on Methadone decreased their heroin use quite rapidly and stopped using heroin in 10-20 years, 15% achieved a modest decrease in their heroin usage but also subsequently stopped using heroin in the next 10-20 years and another 25% decreased their heroin usage.

Methadone has also been found to reduce the frequency of injecting and the sharing of injecting equipment thus also decreasing the risks of transmission of blood borne viruses.

Methadone maintenance treatment improves health, reduces illicit heroin usage, reduces infectious diseases transmission and overdose death. However it’s effectiveness is compromised if low maintenance doses of Methadone are used. Studies have shown that those receiving greater than or equal to 60mg daily doses of Methadone are 70% more likely to remain in treatment than those on doses less than 60mg daily. Degenhardt and his colleagues in 2009 found that Methadone decreases mortality by 29% in this cohort of patients.

Thus in summary Methadone is of vital importance in the optimal treatment of patients in opioid agonist therapy.

Unlocking the Power of Keto
Global Awareness, Healthcare, Lifestyle Matters, MedHeads

Unlocking the Power of Keto

In this episode of Lifestyle Matters.

Can we generate a super fuel in our bodies by eating differently? This week we look at the popular keto diet from a medical perspective.

This diet was originally founded in the 1920s by Russel Wilder to treat epilepsy and it worked! Once anti-epileptic medications were discovered, this diet became less popular until recent times when it became evident that it also helps with weight loss. Truth be told, this diet is still used for some refractory epileptic patients under medical guidance.

A keto diet is essentially a diet we consume to put our body in a state of ketosis. But first, what is ketosis? To understand that we must understand what ketones are.

Ketones are products of fatty acid breakdown e.g., acetoacetate, beta hydroxybutyrate and acetone. These molecules are continuously produced in our bodies in small amounts as part of normal physiological processes.

Ketosis or ketogenesis is a process when our body uses these ketone bodies to provide energy for our cells.

When we eat a well-balanced diet, our body uses carbohydrates as the main source of fuel. So, reducing our consumption of carbohydrates and increasing protein (amino acids) and fat intake allows our body to break down these macronutrients to provide us with energy via processes called gluconeogenesis and ketogenesis respectively.

Ketosis can also happen as part of disease processes e. g . starvation, alcoholism, poorly controlled diabetes and even extreme prolonged exercising. This is obviously dangerous to our health and requires treatment.

Most cells in our body can utilise ketones as a source of energy except our red blood cells and liver. The brain is really good at doing this!

This is how a Keto Diet looks like:

Ketones are called a super fuel because:
100 gm of glucose we can generate 8700 gm ATP
100gm of beta hydroxybutyrate generates 10 500 gm ATP
100gm of acetoacetate generates 9400gm ATP

Apart from being a super fuel, it has various other benefits such as:

  • Treating difficult to control epilepsy

  • Reduce the risk of neurodegenerative conditions e.g. Alzheimer’s Disease

  • Reduces insulin production

  • Increases leptin levels (hormone that tells us we are full hence suppressing our appetite) -> weight loss

  • Reduces LDL, TGL

  • Increases HDL

However, there are some limitations to the Keto diet that suggest that it may not be suitable for everyone.

Those who have certain enzyme deficiencies e. g. pyruvate kinase deficiency, liver failure, and pancreatitis, should not be on this diet due to the high levels of fat and protein intake. There has been also some research to suggest this diet may result in osteoporosis, kidney stones, fatty liver and gout. Further, most studies on the Keto diet have only been conducted over 6 months which means the long-term implications of the diet are still being investigated.

The main point to note is that this is undoubtedly a great diet to follow if it suits one’s lifestyle provided there are no medical contra-indications to it. However, once again it is a diet that we would suggest one to adhere to for a short period (6-12 months) as we have sufficient evidence to support this recommendation, for now at least. Post that period, transitioning to a normal well-balanced diet would be advisable. Ideally, following a whole food predominantly plant-based diet would produce the best outcome.

Methadone - Social Benefits
Cracking Addiction, Global Awareness, Healthcare

Methadone – Social Benefits

On Cracking Addiction this week

Methadone has a number of benefits that extend from not only the person taking it but also society as a whole. Methadone decreases criminality with the overall reduction in convictions and cautions estimated to be at 10% for each six months enrolled in methadone maintenance therapy with patients in continuous treatment receiving the best outcomes.

Generally patients receiving a daily dose of 60 mg or more have better treatment outcomes than those receiving less than 60 mg in terms of:
• Retention in treatment
• Unsanctioned opioid use
• Criminal activity

Methadone is also cost effective with evidence from the National Institute on Drug Abuse in America from 2018 revealing that every dollar invested in addiction treatment programs yields a return of between $4 and $7 in reduced drug-related crime, criminal justice costs, and theft. When savings related to healthcare are included the total savings can exceed costs by a ratio of 12 to 1.

More local evidence from the ‘Final Report of the National Ice Taskforce’ in 2015 in Australia revealed that:
• For every $1 invested in treatment services, more than $7 is returned to the community through health and social benefits.
• For every $1 spent on needle and syringe exchange programs, the community saves $27 in future cost.

Thus in summary Methadone is a cost effect and effective treatment for opioid use disorder that has significant benefits to society as a whole.

The Science of Intermittent Fasting
Global Awareness, Healthcare, Lifestyle Matters, MedHeads

Understanding the Science of Intermittent Fasting

In this episode of Lifestyle Matters.

Benjamin Franklin said that “The best of all medicines are resting and fasting” and we know today that his words have been supported by scientific evidence. Intermittent fasting has been found to reverse early Type 2 diabetes.

The concept of fasting is not new to many especially if we look at the various cultures and religions around the world e.g., Muslims fast during Ramadan, or the various fasts practiced by Hindus and Buddhists. Even Greek philosophers such as Hippocrates and Aristotle have prescribed fasting for various ailments. This week, we look at how and why intermittent fasting works.

We must first understand what happens during the fed and fasted state. When we eat – (predominantly) carbohydrates get broken down into simple sugar molecules. This triggers an insulin response which promotes the uptake of sugar into our cells. Extra sugar (glucose) gets stored in our muscle and fat as glycogen. Leptin levels (which is our satiety hormone) also increases.

When we fast, glucose and insulin levels reduce. This causes our body to search for an alternate source of energy hence processes such as lipolysis and gluconeogenesis begins.
Later on, ketogenesis occurs whereby ketones are produced from the breakdown of fatty acids which is then used a source of energy i.e. ‘the super fuel’

When we fast for prolonged periods of time, our body enters a state of stress adaption whereby it begins certain processes such as cleaning and repairing e.g. DNA repair, protein quality control, increasing expression of anti-oxidant defences etc. As the body enters a fed state, tissue growth and plasticity then begin. However, when we eat ‘normally’ we do not allow our body to switch from a fed to fasting state. Several evidence have pointed the benefits of allowing our body to go through this metabolic switch and these range from:

• Neurodegenerative health: Potentially reducing the risk of dementia as there is an increase in brain derived neurotrophic factor, increased GABA sensitivity etc.
• Improved heart disease profile: Increases HDL (good cholesterol) reduces LDL (bad cholesterol), reduces resting heart rate and blood pressure.
• Reduces risk of diabetes: Reduced insulin resistance as adiponectin levels are increased and leptin levels reduced
• Reduces cancer growth: Mainly documented in glioblastoma multiforme which is an aggressive type of brain tumor, but other cancers are being studied too e.g. breast, ovarian, prostate.

While most studies have been carried out on animals, there are several others underway involving humans. We have observed over time that the profound benefit of this diet is the metabolic switch that occurs and the benefits we can gain from it whether or not there has been weight loss!

It is important to note that this diet is reasonably sustainable and allows us to eat foods we enjoy in moderation. However, no diet is superior if it is not one that suits our lifestyle, and we must always remember that exercise augments the benefits of any diet we follow.

Scroll to Top